Pharmacodynamic modeling of in vitro activity of marbofloxacin against Escherichia coli strains.

Martin Andraud 1 Claire Chauvin 2 Pascal Sanders 1 Michel Laurentie 1
1 Unité de Toxicologie des Contaminants
2 Laboratoire de Ploufragan - Plouzané
Abstract : A mathematical pharmacodynamic model was developed to describe the bactericidal activity of marbofloxacin against Escherichia coli strains with reduced susceptibility levels (determined using MICs) under optimal and intestinal growth conditions. Model parameters were estimated using nonlinear least-square curve-fitting procedures for each E. coli strain. Parameters related to bactericidal activity were subsequently analyzed using a maximum-effect (E(max)) model adapted to account for a direct and a delayed effect. While net growth rates did not vary significantly with strain susceptibility, culture medium had a major effect. The bactericidal activity of marbofloxacin was closely associated with the concentration and the duration of exposure of the bacteria to the antimicrobial agent. The value of the concentration inducing a half-maximum effect (C(50)) was highly correlated with MIC values (R(2) = 0.87 and R(2) = 0.94 under intestinal and optimal conditions, respectively). Our model reproduced the time-kill kinetics with good accuracy (R(2) of >0.90) and helped explain observed regrowth.
Keywords : PHARMACODYNAMY MODELISATION MARBOFLOXACIN ESCHERICHIA COLI PHARMACOKINETIC
Type de document :
Article dans une revue
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2011, 55 (2), pp.756-61. 〈10.1128/AAC.00865-10〉
Liste complète des métadonnées
https://hal-anses.archives-ouvertes.fr/anses-00577909
Contributeur : Emmanuelle Chiffoleau <>
Soumis le : jeudi 17 mars 2011 - 16:56:40
Dernière modification le : jeudi 17 mars 2011 - 16:56:40

Lien texte intégral

openaccess

Identifiants

Collections

ANSES

Citation

Martin Andraud, Claire Chauvin, Pascal Sanders, Michel Laurentie. Pharmacodynamic modeling of in vitro activity of marbofloxacin against Escherichia coli strains.. Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2011, 55 (2), pp.756-61. 〈10.1128/AAC.00865-10〉. 〈anses-00577909〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

76

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD